Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1988 1
1992 1
1998 1
1999 7
2000 3
2001 2
2003 2
2004 5
2005 3
2006 3
2007 2
2008 3
2009 5
2010 7
2011 7
2012 7
2013 2
2014 3
2015 1
2016 5
2017 3
2018 4
2019 3
2021 3
2022 5
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer survival, survival disparities, and guideline-based treatment.
Hill DA, Friend S, Lomo L, Wiggins C, Barry M, Prossnitz E, Royce M. Hill DA, et al. Among authors: royce m. Breast Cancer Res Treat. 2018 Jul;170(2):405-414. doi: 10.1007/s10549-018-4761-7. Epub 2018 Mar 22. Breast Cancer Res Treat. 2018. PMID: 29569018 Free PMC article.
The oral fluorouracil prodrugs.
Pazdur R, Hoff PM, Medgyesy D, Royce M, Brito R. Pazdur R, et al. Among authors: royce m. Oncology (Williston Park). 1998 Oct;12(10 Suppl 7):48-51. Oncology (Williston Park). 1998. PMID: 9830626 Free article. Review.
Everolimus in the Treatment of Metastatic Breast Cancer.
Royce ME, Osman D. Royce ME, et al. Breast Cancer (Auckl). 2015 Sep 6;9:73-9. doi: 10.4137/BCBCR.S29268. eCollection 2015. Breast Cancer (Auckl). 2015. PMID: 26417203 Free PMC article. Review.
U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.
Arora S, Narayan P, Osgood CL, Wedam S, Prowell TM, Gao JJ, Shah M, Krol D, Wahby S, Royce M, Ghosh S, Philip R, Ison G, Berman T, Brus C, Bloomquist EW, Fiero MH, Tang S, Pazdur R, Ibrahim A, Amiri-Kordestani L, Beaver JA. Arora S, et al. Among authors: royce m. Clin Cancer Res. 2022 Mar 15;28(6):1072-1086. doi: 10.1158/1078-0432.CCR-21-2600. Clin Cancer Res. 2022. PMID: 34711632 Free PMC article. Review.
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review.
Arora S, Narayan P, Ison G, Berman T, Suzman DL, Wedam S, Prowell TM, Ghosh S, Philip R, Osgood CL, Gao JJ, Shah M, Krol D, Wahby S, Royce M, Brus C, Bloomquist EW, Fiero MH, Tang S, Pazdur R, Ibrahim A, Amiri-Kordestani L, Beaver JA. Arora S, et al. Among authors: royce m. Clin Cancer Res. 2022 Mar 15;28(6):1058-1071. doi: 10.1158/1078-0432.CCR-21-2599. Clin Cancer Res. 2022. PMID: 34711631 Free PMC article. Review.
Fluoropyrimidines: a critical evaluation.
Brito RA, Medgyesy D, Zukowski TH, Royce ME, Ravandi-Kashani F, Hoff PM, Pazdur R. Brito RA, et al. Among authors: royce me. Oncology. 1999 Jul;57 Suppl 1:2-8. doi: 10.1159/000055262. Oncology. 1999. PMID: 10436410 Review.
Breast disease: benign and malignant.
Meisner AL, Fekrazad MH, Royce ME. Meisner AL, et al. Among authors: royce me. Med Clin North Am. 2008 Sep;92(5):1115-41, x. doi: 10.1016/j.mcna.2008.04.003. Med Clin North Am. 2008. PMID: 18721655 Review.
83 results